Bacterial Lipase Neutralized Toxicity of Lipopolysaccharide on Chicken Embryo Cardiac Tissue

Afsaneh Bagherzadeh1, Hamidreza Vaziri1, Fatemeh Sokouti Nasimi2

  • 1Department of Biology, Faculty of Science, Guilan University, Rasht, Iran.

Insights

Bacterial lipase effectively mitigates lipopolysaccharide (LPS)-induced cardiac toxicity in chicken embryos by modulating Toll-like receptor signaling pathways, offering a protective effect against cardiovascular damage.

Area of Science:

  • Cardiovascular research
  • Immunology
  • Toxicology

Background:

  • Bacterial lipopolysaccharide (LPS) triggers Toll-like receptor (TLR) signaling, adversely affecting organs, particularly the cardiovascular system.
  • Understanding LPS-induced cardiac toxicity is crucial for developing therapeutic interventions.

Purpose of the Study:

  • To investigate the protective effects of bacterial lipase against LPS-induced cardiac tissue toxicity in chicken embryos.
  • To elucidate the molecular mechanisms underlying lipase's protective action.

Main Methods:

  • Chicken embryos were exposed to varying doses of LPS and bacterial lipase.
  • Gene expression (GATA4, NKX2.5, EGFR, TRIF, NF-κB) was analyzed using real-time PCR.
  • NF-κB protein levels were assessed via Western blotting.
  • Antioxidant capacity and enzyme activities were measured.
  • Histological analysis evaluated microvascular density and anterior wall thickness.

Main Results:

  • LPS (1 mg/kbw) increased TRIF expression, while lipase co-administration significantly reduced LPS-induced NF-κB levels.
  • LPS exposure altered cardiac gene expression (GATA4, NKX2.5, EGFR), with lipase partially restoring normal levels.
  • Total antioxidant capacity increased with lipase treatment, while anterior wall thickness was preserved.
  • No significant changes were observed in glutathione peroxidase or catalase activity.

Conclusions:

  • Bacterial lipase demonstrates a blunting effect on LPS-induced cardiac toxicity in chicken embryos.
  • Lipase may exert protective effects by modulating TLR signaling pathways and enhancing antioxidant capacity.
  • These findings suggest potential therapeutic applications for bacterial lipase in managing LPS-related cardiovascular complications.